Newsroom
Sorted by: Latest
-
Thetis Pharmaceuticals Presents New Preclinical and Clinical Data forTP-317 at DDW 2025
ESSEX, Conn.--(BUSINESS WIRE)--Thetis Pharmaceuticals LLC (“Thetis”), a clinical-stage company developing TP-317, a first-in-class, small molecule drug candidate targeting the BLT1 receptor to treat inflammatory bowel disease (IBD) and solid tumor cancers, today announced the presentation of four data sets at Digestive Disease Week (DDW) 2025, held May 3-6 in San Diego, California. The data support TP-317’s advancement as a novel oral therapy for both IBD and microsatellite stable (MSS) colorec...
-
CORRECTING and REPLACING Primoris Services Corporation Reports First Quarter 2025 Results
DALLAS--(BUSINESS WIRE)--In the CONDENSED CONSOLIDATED STATEMENTS OF INCOME, Revenue for the Three Months Ended March 31, 2025, should be $1,648,112 (instead of $81,648,112). The updated release reads: PRIMORIS SERVICES CORPORATION REPORTS FIRST QUARTER 2025 RESULTS Primoris Services Corporation (NYSE: PRIM) (“Primoris” or the “Company”) today announced financial results for its first quarter ended March 31, 2025 and provided comments on the Company’s operational performance and outlook for 202...
-
Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 Dry Eye Disease Chamber Trial of Reproxalap and Plans NDA Resubmission
LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced the achievement of the primary endpoint in a Phase 3 randomized, double-masked, vehicle-controlled dry eye chamber trial of 0.25% reproxalap ophthalmic solution, an investigational new drug candidate, for the treatment of dry eye disease. For the prespec...
-
Beach Cities Commercial Bank Announces First Quarter 2025 Financial Results
IRVINE, Calif,--(BUSINESS WIRE)--Beach Cities Commercial Bank, www.beachcitiescb.com (OTCQB: BCCB) (the "Bank"), today announced financial results for the quarter ended March 31, 2025. The Bank was incorporated under the laws of the State of California on April 11, 2022. The Bank opened for business on June 12, 2023, after receiving all necessary regulatory approvals, and it began providing a full range of banking services from its branch locations in Irvine and Encinitas, California. The Bank...
-
Pershing Square Holdings, Ltd. Provides Director Declaration – UKLR 6.4.9R
LONDON--(BUSINESS WIRE)--In accordance with UKLR 6.4.9R, Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) today notes that PSH Board member Jean-Baptiste Wautier has been appointed as non-executive independent director of Howard Hughes Holdings Inc., which is traded on the New York Stock Exchange, with effect from 5 May 2025. Mr. Wautier remains an independent non-executive director of PSH. About Pershing Square Holdings, Ltd. Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) is an investment...
-
Pershing Square Holdings, Ltd. (“PSH”) Notes the Transaction Announced Today by Howard Hughes Holdings (“HHH”) and PSH’s Investment Manager
LONDON--(BUSINESS WIRE)--Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) today noted that its investment manager, Pershing Square Capital Management, L.P. (the “Investment Manager”), the Investment Manager’s holding company, Pershing Square Holdco, L.P. (“Holdco”, and together with the Investment Manager, “Pershing Square”), and Howard Hughes Holdings, Inc. jointly issued the following release announcing Holdco’s investment of $900 million to acquire nine million newly issued shares of HHH: h...
-
Labaton Keller Sucharow LLP Announces Securities Class Action Lawsuit Filed Against West Pharmaceutical Services, Inc. and Certain of Its Executives
NEW YORK--(BUSINESS WIRE)--Labaton Keller Sucharow LLP (“Labaton”) announces that, on May 5, 2025, it filed a securities class action lawsuit (the “Complaint”) on behalf of its client the New England Teamsters Pension Fund (“New England Teamsters”) against West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST) and certain West executives (collectively, “Defendants”). The action, which is captioned New England Teamsters Pension Fund v. West Pharmaceutical Services, Inc., No. 25...
-
Bancroft Capital Names Katherine Kullmann VP of Municipal Underwriting
FORT WASHINGTON, Pa.--(BUSINESS WIRE)--Bancroft Capital, a certified Service-Disabled Veteran-Owned Small Business (SDVOSB), announces the hiring of Katherine Kullmann as Vice President of Municipal Underwriting. Kullmann will serve as the primary negotiated underwriter working out of the firm’s Fort Washington headquarters. “Katherine is a tremendous addition to our municipal team,” said CEO Cal Quinn. “Her hiring continues to demonstrate our commitment to providing exceptional, value-added se...
-
Resecurity Joins U.S.-U.A.E. Business Council to Strengthen Cybersecurity Collaboration in the Middle East
LOS ANGELES--(BUSINESS WIRE)--Resecurity®, a leading U.S.-based cybersecurity company, proudly announces its official membership in the U.S.-U.A.E. Business Council, a premier organization dedicated to advancing commercial ties between the United States and the United Arab Emirates. The U.S.-U.A.E. Business Council plays a pivotal role in enhancing the bilateral relationship between the United States and the U.A.E. through high-level engagement with business and government leaders. It provides...
-
Heidrick & Struggles ernennt neuen Managing-Partner zu seinem CEO & Board Practice in Europa und Afrika
LONDON--(BUSINESS WIRE)--Heidrick & Struggles (Nasdaq: HSII), ein führender Anbieter im Bereich Executive Search Dienstleistungen, in globaler Führungsberatung und bei Talent-Lösungen auf Anfrage, hat Kati Najipoor-Smith zum Regional Co-Managing Partner, CEO & Board Practice für Europa und Afrika ernannt. Von ihrem Büro in Frankfurt (Deutschland) aus bringt sie jahrzehntelange globale Executive Search- und Beratungserfahrung in das Heidrick & Struggles Team ein, um Vorstände und CEO...